Back to mobile site

PTC Therapeutics (PTCT) PT Lowered to $46 at RBC Capital

November 6, 2018 6:46 AM EST Send to a Friend
RBC Capital analyst Brian Abrahams lowered the price target on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login